Heramed Ltd Suspended from Quotation
Key points
- Heramed Ltd suspended from quotation under Listing Rule 17.5
- Suspension due to not lodging relevant periodic report by due date
- Reinstatement possible if report lodged before suspension imposed
Full summary
Heramed Ltd has been suspended from quotation on the Australian Securities Exchange (ASX) under Listing Rule 17.5 for not lodging the relevant periodic report by the due date. The suspension will take effect from the commencement of trading on Friday, 1 August 2025. If the report is lodged between the closure of the market announcements office on Thursday, 31 July 2025, and the imposition of the suspension, Heramed Ltd's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. The announcement also states that Antilles Gold Limited (AAU) and Syntara Limited (SNT) have been suspended from quotation for the same reason.
Summary generated by a large language model. Please interpret with care.